94701 ⎘
Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms 1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
#302Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists
#303Crystalline substituted 5-fluoro-1H-pyrazolopyridines and process for preparing
#304PROCESS FOR THE SYNTHESIS OF DIFLUOROMETHYL ETHER-BASED COMPOUNDS
#305Cyclopropylamines as LSD1 inhibitors
#306Method for preparing cellulose dope
#307Ethynylbenzene derivatives
#308DERIVATIVES OF BETULIN
#309Hepatitis B antiviral agents
#310Piperazine carbamates and methods of making and using same
#311Compounds as anti-tubercular agents
#312Synthesis of copanlisib and its dihydrochloride salt
#313Neprilysin inhibitors
#314Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) agonists
#315Aminoindane-, aminotetrahydronaphthalene- and aminobenzocyclobutane-derived PRMT5-inhibitors
#3164-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
#317Phosphinyl amidine compounds, metal complexes, catalyst systems, and their use to oligomerize or polymerize olefins
#318Pharmacologically active compounds
#319Arylquinazolines
#320Nitrogen containing hydrofluoroethers and methods of using same
#321Benzimidazole Inhibitors of the Sodium Channel
#322Compounds and compositions for treating HIV with derivatives of Betulin
#323Heterocyclic compounds as NaV channel inhibitors and uses thereof
#324IDO inhibitors
#325HIV protease inhibitors
#326Hydrophilic oil repellent and production method of same, surface coating material, coating film, resin composition, oil-water separation filter material, and porous body
#327Substituted cyano cycloalkyl penta-2,4-dienes, cyano cycloalkyl pent-2-en-4-ynes, cyano heterocyclyl penta-2,4-dienes and cyano heterocyclyl pent-2-en-4-ynes as active substances against abiotic plant stress
#328Oil-water separation apparatus and drainage system
#329Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
#330Hydrofluoroether olefins and methods of using same
#331Cyclopropylamine compounds as histone demethylase inhibitors
#332AMIDE COMPOUNDS, METHODS FOR PREPARATION, AND USE THEREOF AS AGENTS FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY RNA- AND/OR DNA-CONTAINING VIRUSES, AND CONCOMITANT DISEASES
#333Compounds for the treatment of cancer and inflammatory disease
#334Process for the synthesis of sulfones and sulfonamides
#335Process for preparing substituted 5-fluoro-1H-pyrazolopyridines
#336Compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same
#337HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL
#338Compounds useful as immunomodulators
#339Treprostinil derivative compounds and methods of using same
#340Decarboxylative cross-coupling and applications thereof
#341Neprilysin inhibitors
#342Treprostinil derivative compounds and methods of using same
#343(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide
#344Antibacterial agents: Nα-aroyl-N-aryl-phenylalaninamides
#345Antidiabetic compounds
#346Amyloid targeting agents and methods of using the same
#347Pharmacologically active compounds
#348HIV protease inhibitors
#349Lipids and lipid compositions for the delivery of active agents
#350Methods for producing viloxazine salts and novel polymorphs thereof
#351Viral replication inhibitors
#352N-substituted benzamides and methods of use thereof
#353HIV protease inhibitors
#354Process for the preparation of chiral 2-aryl morpholines
#355IDO inhibitors
#356Piperazine carbamates and methods of making and using same
#357Substituted benzamides
#358Phosphine ligands for catalytic reactions
#359Benzathine analogs
#360FBXO3 inhibitors
#361Glucosylceramide synthase inhibitors for the treatment of diseases
#362Cyclopropylamines as LSD1 inhibitors
#363Compounds useful as immunomodulators
#364Therapeutic agent for ophthalmic disease
#365N-heterocyclic carbene type palladium catalyst and its preparation method as well as applications
#366Phosphinyl amidine compounds, metal complexes, catalyst systems, and their use to oligomerize or polymerize olefins
#3675,6-dihydro-2H-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (BACE)
#368Bisaryl (thio)morpholine derivatives as S1P modulators
#369Aminomethyl-Biaryl Derivatives Complement Factor D inhibitors and uses thereof
#370Nitrogen-containing saturated heterocyclic compound
#371Nitrogen containing hydrofluoroethers and methods of making same
#372Onium salt compound, resist composition, and pattern forming process
#3731-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
#374Compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same
#375Compounds and uses thereof for the modulation of hemoglobin
#376COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
#3774-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
#378NOVEL COMPOUNDS
#379Histone deacetylase inhibitors and compositions and methods of use thereof
#380Heterocyclic inhibitors of the sodium channel
#381Process for preparing substituted 5-fluoro-1H-pyrazolopyridines
#382Neprilysin inhibitors
#383(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide
#384Benzimidazole inhibitors of the sodium channel
#385STAT3 inhibitor
#386Phosphine ligands for catalytic reactions
#387Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof
#388Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof
#389Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof
#390Derivatives of the sinapinic acid
#391Hydroxy aliphatic substituted phenyl aminoalkyl ether derivatives
#392Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof
#393Autotaxin inhibitors
#394Benzyl sulfonamide compounds useful as MoGAT-2 inhibitors
#395Heterocyclic compounds as NaV channel inhibitors and uses thereof
#396Hepatitis B antiviral agents
#397Potassium channel blockers
#398Substituted benzamides and methods of use thereof
#399Acetamide derivatives
#400ATX modulating agents
#401(Thio)morpholine derivatives as S1P modulators
#402Renin inhibitor
#403Method of Maintaining Oral Health in Animals
#404Hydroxamic acid derivative
#405Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance
#406Substituted phenylcarbamate compounds
#407Derivatives of Betulin
#408Cycloalkyl-diamines
#409Bisaryl (thio)morpholine derivatives as S1P modulators
#410Treprostinil derivative compounds and methods of using same
#411Phosphine ligands for catalytic reactions
#412Hepatitis B antiviral agents
#413Benzathine analogs
#414COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
#415Viloxazine compositions
#416Substituted biphenyl amides as P2Xand P2Xantagonists
#417Compounds
#418Bumetanide analogs, compositions and methods of use
#419Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
#420Cycloalkyl Amine Compounds
#421Thrombin inhibitors
#422DERIVATIVES OF PHENOXYISOBUTYRIC ACID
#423Cyclopropylamines as LSD1 inhibitors
#424Process for preparing substituted 5-fluoro-1H-pyrazolopyridines
#425MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO
#426Compounds and uses thereof for the modulation of hemoglobin
#427Treprostinil derivative compounds and methods of using same
#428Oxazine derivatives and their use in the treatment of disease
#429System and method for extraction of chemicals from lignocellulosic materials
#430Phosphinyl amidine compounds, metal complexes, catalyst systems, and their use to oligomerize or polymerize olefins
#431Potassium channel blockers
#432Method for the preparation of substituted oxazolidinones
#433HIV protease inhibitors
#434Apoptosis promoters
#435Hepatitis B antiviral agents
#436Hepatitis B antiviral agents
#437Autotaxin inhibitors
#438Morpholino compounds, uses and methods
#439PROCESSES AND REAGENTS FOR MAKING DIARYLIODONIUM SALTS
#440NEUROTROPHIN MIMETICS AND USES THEREOF
#441Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance
#4422,5-disubstituted arylsulfonamide CCR3 antagonists
#443Cyclopentadienyl, indenyl or fluorenyl substituted phosphine compounds and their use in catalytic reactions
#444Methods of Use for Monomethyl Fumarate and Prodrugs Thereof
#445PIPERAZINE PDE4 INHIBITORS AND USES THEREOF
#446Phenoxy acetic acids and phenyl propionic acids as PPARδ agonists
#447Cyclopropylamines as LSD1 inhibitors
#448Method of inhibiting tau phosphorylation
#449Nitrogen-containing saturated heterocyclic compound
#450Substituted morpholines as modulators for the calcium sensing receptor
#451Process for preparation of Linezolid and its novel intermediates
#452N-substituted benzamides and methods of use thereof
#453N-substituted benzamides and methods of use thereof
#4541-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
#4554-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
#456Substituted 4-aminobenzamides as KCNQ2/3 modulators
#457Ethynylbenzene derivatives
#458Phosphine ligands for catalytic reactions
#459Morpholinoalkyl fumarate compounds, pharmaceutical compositions, and methods of use
#460Phenylmorpholines and analogues thereof
#461Bisaryl (thio)morpholine derivatives as S1P modulators
#462Use of compound binding to mSin3B that specifically binds to neuron restrictive silencer factor (NRSF)
#463Methods for inhibiting muscle atrophy
#4643-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-aminopropionic acid amides and related compounds having analgesic and/or immuno stimulant activity
#4653-AMINO-5-PHENYL-56-DIHYDRO-2H-[1,4]OXAZINES
#466Apoptosis promoters
#467Benzyl sulfonamide derivatives as RORc modulators
#468Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
#469Cannabinoid receptor modulators
#470Pyridinyl amides as P2X3 and P2X2/3 inhibitors
#471Process for the manufacture of chiral catalysts and their salts
#472Process for preparing substituted 5-fluoro-1H-pyrazolopyridines
#4735,6-DIHYDRO-2H-[1,4]OXAZIN-3-YL-AMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)
#474Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof
#475Substituted tetracycline compounds
#476Phenoxy acetic acids as PPAR delta activators
#477Substituted aminopropionic derivatives as neprilysin inhibitors
#478Arylsulfonamide based matrix metalloprotease inhibitors
#479Compounds useful as inhibitors of ATR kinase
#480Hydroxamic acid derivative
#481Aralkyl diamine derivatives and uses thereof as antidepressants
#4822,5-disubstituted arylsulfonamide CCR3 antagonists
#483METHOD OF PREVENTING AND/OR TREATING DIABETIC NEUROPATHY
#484Quaternary heteroatom containing compounds
#4853-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity
#486Compounds which modulate the CB2 receptor
#487Substituted benzamide derivatives
#488Phosphinyl amidine compounds, metal complexes, catalyst systems, and their use to oligomerize or polymerize olefins
#489Benzoimidazole compounds and uses thereof
#490Heterocyclic Compounds as CCR2 Antagonists
#491Arylsulfonamide based matrix metalloprotease inhibitors
#492Cyclopentadienyl, indenyl or fluorenyl substituted phosphine compounds and their use in catalytic reactions
#493Heterocyclic amine derivatives
#494Oxazine Derivatives and their Use in the Treatment of Neurological Disorders
#495CATALYSTS AND BORONATE ESTERS
#496Methods of using as analgesics 1-benzyl-1-hydroxy-2, 3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds
#497(Thio)morpholine derivatives as S1P modulators
#4983-AMINO-5-PHENYL-5,6-DIHYDRO-2H-[1,4]OXAZINES
#4991,4 oxazines as BACE1 and/or BACE2 inhibitors
#5001,4 oxazines as BACE1 and/or BACE2 inhibitors
#501Compounds having analgesic and/or immunostimulant activity
#5024-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
#503Calcium sensing receptor modulating compounds and pharmaceutical use thereof
#504Phenoxy substituted phenylamidine derivatives and their use as fungicides
#505Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
#506Composition for treatment of tuberculosis
#507ARYL ANILINE DERIVATIVES AS BETA2 ADRENERGIC RECEPTOR AGONISTS
#508Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
#509Novel Therapeutic Compounds
#510Process for producing 2-hydroxymethylmorpholine salt
#511Cyclic hydroxylamine as psychoactive compounds
#512Cyclohexane derivative having NPY Y5 receptor antagonism
#513BUMETANIDE, FUROSEMIDE, PIRETANIDE, AZOSEMIDE, AND TORSEMIDE ANALOGS, COMPOSITIONS AND METHODS OF USE
#514Camphor-derived β-amino alcohol compounds, method for manufacturing the same and asymmetric addition of organozinc to aldehydes using the same
#515NOVEL THERAPEUTIC COMPOUNDS
#516GLP-1 receptor stabilizers and modulators
#517Process for the preparation and purification of amorolfine hydrochloride
#5181-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
#519Acetanilide sphingosine-1-phosphate receptor antagonists
#520N-acyl anthranilic acid derivative or salt thereof
#521Method of Maintaining Oral Health in Animals
#522INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF
#523Apoptosis promoters
#524INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF
#525Methods for producing viloxazine salts and novel polymorphs thereof
#526Phenyl propionic acids as PPAR delta activators
#527NEUROTROPHIN MIMETICS AND USES THEREOF
#528Latent acids and their use
#529AQUAPORIN MODULATORS AND METHODS OF USING THEM FOR THE TREATMENT OF EDEMA AND FLUID IMBALANCE
#530Method of maintaining oral health in animals
#531NOVEL SALT OF MORPHOLINE DERIVATIVE
#532NOVEL PHARMACEUTICAL COMPOSITION FOR TREATING NOCICEPTIVE PAIN
#533Substituted benzamides
#534Apoptosis promoters
#535Heterocyclic Compounds as CCR2 Antagonists
#536Cyclopropyl amines as modulators of the histamine Hreceptor
#537Cyclohexane derivatives and uses thereof
#538Process for the preparation of delmopinol and derivatives thereof
#539Class of histone deacetylase inhibitors
#540SUBSTITUTED PHENYLAMINO-BENZENE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH MITOGEN EXTRACELLULAR KINASE ACTIVITY
#541Piperazine PDE4 inhibitors and uses thereof
#542Therapeutic piperazines
#543PIPERAZINES AS ANTI-OBESITY AGENTS
#544Morpholinone compounds as factor IXa inhibitors
#545ACETYL MIMIC COMPOUNDS FOR THE INHIBITION OF ISOPRENYL-S-CYSTEINYL METHYLTRANSFERASE
#546NEW COMPOUNDS I
#5473-amino-5-phenyl-5,6-dihydro-2H-[1,4]oxazines
#548SUBSTITUTED PHENOXYBENZAMIDES
#549Niacin Receptor Agonists, compositions Containing Such Compounds and Methods of Treatment
#550Oxazine derivatives and their use in the treatment of neurological disorders
#551Arylsulfonamide-based matrix metalloprotease inhibitors
#552Biphenyl amides as P2Xand P2Xantagonists
#553Renin Inhibitors
#554Substituted aminopropionic derivatives as neprilysin inhibitors
#555Substituted tetracycline compounds
#556Aryl potassium channel blockers and uses thereof
#557METHOD AND AGENT FOR REFOLDING PROTEINS
#558PROCESS FOR PRODUCTION OF 4- (SUBSTITUTED PHENYL) HEXAHYDROPYRIDO [2,1-C] [1,4] OXAZIN-6-ONE
#559Derivatives Of Hydroxamic Acid As Metalloproteinase Inhibitors
#560NOVEL ANALGESIC THAT BINDS FILAMIN A
#561Amine derivatives having NPY Y5 receptor antagonistic activity and the uses thereof
#5622,5-disubstituted arylsulfonamide CCR3 antagonists
#563Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
#564Amine derivative having NPY Y5 receptor antagonistic activity
#565Amide and amidine derivatives and uses thereof
#566Cyclic hydroxylamine as psychoactive compounds
#567Morpholine derivative
#568Isophthalates as beta-secretase inhibitors
#569Process for the preparation of delmopinol and derivatives thereof
#570N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS
#571BENZAMIDE DERIVATIVES, THEIR PREPARATION AND USES IN MEDICINE THEREOF
#572DIARYL MORPHOLINES AS CB1 MODULATORS
#573Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
#574NOVEL COMPOUNDS USEFUL AS CC CHEMOKINE RECEPTOR LIGANDS
#5753-SUBSTITUTED PHENOXYPHENYLAMIDINES AND USE THEREOF AS FUNGICIDES
#576Modified malonate derivatives
#577Morpholine Compounds, Pharmaceutically Acceptable Salts Thereof, Pharmaceutical Compositions, and Methods Of Use Thereof
#578Cyclopropyl amines as modulators of the histamine Hreceptor
#579Renin Inhibitors
#580NOVEL PREVENTIVE AND/OR THERAPEUTIC AGENT FOR DIABETIC NEUROPATHY
#581CATIONIC LIPIDS AND USES THEREOF
#582BETA-CARBOLINES USEFUL FOR TREATING INFLAMMATORY DISEASE
#583Substituted N-arylsulfonylheterocyclic amines as gamma-secretase inhibitors
#584Potassium channel blockers
#585Potassium channel blockers
#586Substituted N-Arylsulfonylheterocyclic Amines As Gamma-Secretase Inhibitors
#587Aryl aniline derivatives as βadrenergic receptor agonists
#588HETEROCYLIC COMPOUNDS CONTAINING THE MORPHOLINE NUCLEUS THEIR PREPARATION AND USE
#589NOVEL FORMS OF REBOXETINE
#590Ortho-aminoanilides for the treatment of cancer
#591SUBSTITUTED ANILINE DERIVATIVES
#592Amine derivative having NPY Y5 receptor antagonistic activity
#593GLUCOSE METABOLISM STIMULATING AGENT
#594Diaryl Compounds and Uses Thereof
#595Compounds which modulate the CB2 receptor
#596MTP inhibiting tetrahydro-naphthalene-1-carboxylic acid derivatives
#597Compounds having analgesic and/or immunostimulant activity
#598Cyclic hydroxylamine as psychoactive compounds
#599PHARMACEUTICAL SALTS OF REBOXETINE
#600CYSTEINE PROTEASE INHIBITORS